Biotage AB
STO:BIOT
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
114.9721
200.8
|
Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one BIOT stock under the Base Case scenario is 191.22 SEK. Compared to the current market price of 163 SEK, Biotage AB is Undervalued by 15%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Biotage AB
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for BIOT cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Biotage AB
Balance Sheet Decomposition
Biotage AB
Current Assets | 1.2B |
Cash & Short-Term Investments | 318m |
Receivables | 409m |
Other Current Assets | 475m |
Non-Current Assets | 3.6B |
Long-Term Investments | 25m |
PP&E | 300m |
Intangibles | 3.3B |
Other Non-Current Assets | 29m |
Current Liabilities | 639m |
Accounts Payable | 64m |
Other Current Liabilities | 575m |
Non-Current Liabilities | 416m |
Long-Term Debt | 221m |
Other Non-Current Liabilities | 195m |
Earnings Waterfall
Biotage AB
Revenue
|
2.1B
SEK
|
Cost of Revenue
|
-774m
SEK
|
Gross Profit
|
1.3B
SEK
|
Operating Expenses
|
-961m
SEK
|
Operating Income
|
351m
SEK
|
Other Expenses
|
-101m
SEK
|
Net Income
|
250m
SEK
|
Free Cash Flow Analysis
Biotage AB
SEK | |
Free Cash Flow | SEK |
Biotage reported strong Q1 results with revenues of SEK 480 million, a 33% increase from last year, and a gross margin of 63.1%. Recurring revenues rose significantly to 72%, largely due to the Astrea business, which grew by 78% year-on-year. The Biologics and Advanced Therapeutics division now accounts for 30% of total revenue, up from 4% last year. However, the company faced challenges in meeting the high demand in the peptide business, which prevented additional growth. Biotage is investing in increasing production capacity to meet future demand. Overall, the company is optimistic about continued growth in the peptide segment and new product launches.
What is Earnings Call?
BIOT Profitability Score
Profitability Due Diligence
Biotage AB's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
Score
Biotage AB's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
BIOT Solvency Score
Solvency Due Diligence
Biotage AB's solvency score is 77/100. The higher the solvency score, the more solvent the company is.
Score
Biotage AB's solvency score is 77/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BIOT Price Targets Summary
Biotage AB
According to Wall Street analysts, the average 1-year price target for BIOT is 218.03 SEK with a low forecast of 161.6 SEK and a high forecast of 288.75 SEK.
Dividends
Current shareholder yield for BIOT is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
BIOT Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Biotage AB engages in the provision of separation and synthesis technology solutions. The company is headquartered in Uppsala, Uppsala and currently employs 497 full-time employees. The company went IPO on 2000-06-30. Its customers include pharmaceutical and biotechnology companies, companies within the food industry and academic institutions. The firm offers systems and services within three areas: analytical chemistry, organic chemistry and industrial resins. Biotage’s offering within analytical chemistry consists of consumables with related applications to extract selected substances from various types of samples. The Company’s offering within organic chemistry includes products for pharmaceutical development based on both small molecules and peptides and its offering within industrial resins is composed of polymer-based resins and research services that lead to the development and manufacture of polymer-based materials. As of December 31, 2013, the Company operated 12 wholly owned subsidiaries worldwide.
Officers
The intrinsic value of one BIOT stock under the Base Case scenario is 191.22 SEK.
Compared to the current market price of 163 SEK, Biotage AB is Undervalued by 15%.